✦ LIBER ✦

A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction

✍ Scribed by Byung-Jo Kang; Seung-Jae Lee; Moon-Doo Kim; Man-Je Cho

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 63 KB
Volume: 17
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.409

No coin nor oath required. For personal study only.

✦ Synopsis

The aim of this study was to examine the effect of Ginkgo biloba on antidepressant-induced sexual dysfunction. The Ginkgo biloba (n=19) and the placebo groups (n=18) were divided; each to be administered with Ginkgo biloba and placebo respectively for 2 months by means of a randomized placebo-controlled, double-blind study. The results of this 2 month trial were: (1) there was no statistical significant difference from the placebo at weeks 2, 4 and 8 after medication; (2) in comparison with baseline, both the Ginkgo biloba group and the placebo group showed improvement in some part of the sexual function, which is suggestive of the importance of the placebo effect in assessing sexual function. This study did not replicate a prior positive finding supporting the use of Ginkgo biloba for antidepressant, especially SSRI, induced sexual dysfunction.

📜 SIMILAR VOLUMES

Triple-blind, placebo-controlled trial o

Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs

✍ David Wheatley 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

## Abstract A triple‐blind (investigator, patient, statistician), randomized, placebo‐controlled, trial of __Ginkgo biloba__ 240 mg daily was carried out. Following a 1‐week control, it was given to 24 patients with sexual impairment due to antidepressant drugs. Efficacy analysis was carried out on

Ginkgo biloba for mild to moderate demen

Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial

✍ Rob McCarney; Peter Fisher; Steve Iliffe; Robbert van Haselen; Mark Griffin; Jan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract ## Objectives Doubt over the cost‐effectiveness of the cholinesterase inhibitors in dementia has renewed interest in alternative treatments such as Ginkgo biloba. We aimed to determine the effectiveness and the safety profile of Ginkgo biloba for treating early stage dementia in a comm

A double-blind, placebo-controlled, rand

A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings

✍ Joseph A. Mix; W. David Crews Jr. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

There appears to be an absence of large-scaled clinical trials that have examined the efficacy of Ginkgo biloba extract on the neuropsychological functioning of cognitively intact older adults. The importance of such clinical research appears paramount in light of the plethora of products containing

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Steroid injection for osteoarthritis of

Steroid injection for osteoarthritis of the hip: A randomized, double-blind, placebo-controlled trial

✍ Robert G. W. Lambert; Edna J. Hutchings; Michael G. A. Grace; Gian S. Jhangri; B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease

✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s